U.S. markets closed
  • S&P 500

    3,901.36
    +0.57 (+0.01%)
     
  • Dow 30

    31,261.90
    +8.77 (+0.03%)
     
  • Nasdaq

    11,354.62
    -33.88 (-0.30%)
     
  • Russell 2000

    1,773.27
    -2.96 (-0.17%)
     
  • Crude Oil

    110.35
    +0.46 (+0.42%)
     
  • Gold

    1,845.10
    +3.90 (+0.21%)
     
  • Silver

    21.76
    -0.14 (-0.65%)
     
  • EUR/USD

    1.0562
    -0.0026 (-0.24%)
     
  • 10-Yr Bond

    2.7870
    -0.0680 (-2.38%)
     
  • GBP/USD

    1.2495
    +0.0020 (+0.16%)
     
  • USD/JPY

    127.8500
    +0.0560 (+0.04%)
     
  • BTC-USD

    30,029.72
    +684.80 (+2.33%)
     
  • CMC Crypto 200

    650.34
    -23.03 (-3.42%)
     
  • FTSE 100

    7,389.98
    +87.24 (+1.19%)
     
  • Nikkei 225

    26,739.03
    +336.19 (+1.27%)
     

Former Albertsons CEO Ups His Medicine Man Tech Investment To $21M

Medicine Man Technologies Inc (OTC: MDCL) announced that Dye Capital & Company is increasing its investment in the company from $14 million to $21 million.

Justin Dye, Dye Capital Management Partner, is stepping up to serve as Medicine Man Technologies' Chairman of the Board. Dye was a leader in Albertsons Companies as it expanded its transactions to over $40 billion.

Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 -- Click here to learn more!

"Dye Capital is a strong private equity partner with a deep and thorough understanding of finance and acquisition strategies, which is why their increase in investment in Medicine Man Technologies demonstrates confidence and strengthens the path we have been paving since inception," Medicine Man Tech CEO Andy Williams told Benzinga. "We continue to build our company organically and are forming a coalition of the industry’s finest so that the Medicine Man Technologies brand remains a true cutting-edge industry leader to guide others in this burgeoning sector."

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.